Finerenone in patients with heart failure and deterioration in eGFR to <25ml/min/1.73m2 in the FINEARTS-HF Trial
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
5 More presentations in this session
Associate Professor N. Bergh (Gothenburg, SE)
Doctor A. D'Amato (Rome, IT)
Associate Professor J. Park (Seongnam, KR)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
